^
BIOMARKER:

High MHC-II signature

News
Twitter
Trials
High MHC-II signature
Bladder Cancer
sunitinib
Sensitive: C3 – Early Trials
High MHC-II signature
Bladder Cancer
NU7441
Sensitive: C3 – Early Trials
High MHC-II signature
Bladder Cancer
docetaxel
Sensitive: C3 – Early Trials
High MHC-II signature
Bladder Cancer
cisplatin
Sensitive: C3 – Early Trials